Quantifying the Inhibitory Efficacy of HIV-1 Therapeutic Interfering Particles at a Single CD4 T-Cell Resolution

Area of Science:

• Virology
• Immunology
• Mathematical Biology

Background:

• Highly active antiretroviral therapy (HAART) controls HIV-1 but is not curative.
• Therapeutic Interfering Particles (TIPs), engineered from defective interfering particles (DIPs), show potential for HIV-1 therapy.
• Discrepancies exist between animal model efficacy and human clinical trial results for DIPs in HIV-1 treatment.

Purpose of the Study:

• To quantitatively model intracellular HIV-1 replication in the presence of TIPs.
• To investigate the interference of a specific engineered TIP-2 particle with HIV-1 replication.
• To define conditions for reducing wild-type HIV-1 replication number using TIP-2 particles.

Main Methods:

• Development of a high-resolution deterministic mathematical model.
• Simulation of HIV-1 replication dynamics within CD4+ T cells.
• Analysis of TIP-2 particle interference based on viral load and particle ratios.

Main Results:

• A ratio of 1 HIV-1 to 10 TIP-2 particles reduced viral production to approximately two virions per cycle.
• Pre-activation of the interferon type I (IFN-I) system completely blocked HIV-1 production in TIP-2 co-infected cells.
• Mathematical modeling provided insights into intracellular HIV-1 replication dynamics under TIP interference.

Conclusions:

• TIPs alone may not be sufficient for complete HIV-1 eradication.
• Combining TIPs with other antiviral strategies, such as interferon therapy, could enhance treatment effectiveness.
• Mathematical modeling is crucial for understanding HIV-TIP interactions and developing combination therapies.